30-Jun-2025
Cancer: «forgotten» cells go on the offensive
Université de GenèvePeer-Reviewed Publication
In the fight against cancer, immunotherapy – which aims to boost the body’s natural defences against cancer - is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes, ‘‘killer cells’’ able to eliminate diseased cells. A team from the University of Geneva (UNIGE) has explored an alternative approach involving CD4 T lymphocytes. Long considered mere auxiliary cells, their therapeutic potential has been considered of secondary importance. But the scientists have discovered that they also have strong killing capacity, while continuing to support other immune cells. Using cell engineering technologies, the team reprogrammed the cells to target a tumour marker found in many cancers, both in adults and children. These results, published in the journal Science Advances, offer hope for a faster therapeutic strategy that could benefit a greater number of patients.
- Journal
- Science Advances